291650 — Aptamer Sciences Income Statement
0.000.00%
Last trade - 00:00- KR₩31bn
- KR₩16bn
- KR₩1bn
Annual income statement for Aptamer Sciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 229 | 269 | 358 | 243 | 1,083 |
| Cost of Revenue | |||||
| Gross Profit | -974 | -1,080 | -1,222 | -1,620 | -1,634 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,151 | 4,336 | 8,678 | 12,450 | 7,952 |
| Operating Profit | -3,923 | -4,067 | -8,320 | -12,207 | -6,869 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3,843 | -3,831 | -8,301 | -13,602 | -8,702 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3,843 | -3,831 | -7,116 | -13,602 | -8,702 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3,843 | -3,831 | -7,116 | -13,602 | -8,702 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -3,843 | -3,831 | -7,116 | -13,602 | -8,702 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -218 | -194 | -358 | -684 | -526 |
| Dividends per Share |